The Effectiveness of Spermotrend Food Supplement in the Treatment of Male Infertility

  • STATUS
    Recruiting
  • days left to enroll
    77
  • participants needed
    80
  • sponsor
    Catalysis SL
Updated on 22 March 2022
urinary symptoms
benign prostatic hyperplasia
hyperplasia

Summary

Spermotrend is a natural based product manufactured by Catalysis Laboratories. Its composition contains different essential elements for spermatogenesis: selenium, zinc and fructose. In addition, it contains L-arginine, natural precursor of nitric oxide that favors vasodilation, and pygeum africanum extract with antioxidant, antiinflammatory, antiandrogenic and antiproliferative action.

Its main action resides in the control of oxidative damage to the tissues of the male reproductive system, as well as the control of correct spermatogenesis.

Given that sperm quality can be altered by oxidative stress and that male infertility affects more and more people, the prevention and management of this deterioration becomes increasingly important.

Therefore, to evaluate Spermotrend as a new therapy for male infertility, the investigators are going to study the safety and efficacy of this treatment in this clinical trial.

RESEARCH HYPOTHESIS

The treatment with Spermotrend improves the parameters of the spermatogenesis.

GENERAL OBJECTIVES

To evaluate the effectiveness and the safety level of the natural Spermotrend product in the treatment of male infertility.

SPECIFIC OBJECTIVES

  • Evaluate the increase in sperm motility and concentration.
  • Identify the improvement in the seminal fluid volume.
  • Identify the positive changes in the sperm morphology.
  • Determine how to maintain the semen analysis in a normal range.
  • Describe the adverse effects.

SECONDARY OBJECTIVES

  • Identify the improvement in urinary symptoms related with benign prostatic hyperplasia.
  • Identify the improvement in varicocele.

Description

Every day, all over the world, increasingly more couples have to go to specialised centres in the hope of solving their infertility problems. In the past, female infertility was thought to be the main cause of this problem, but in the course of time, those of us who work in the field of Gynaecology, which is such a delicate issue, are convinced that the initial statistics concerning the prevalence of infertility in women is now just pure myth. The male factor is the main cause of infertility in numerous couples that go to the doctor every day, the percentage of which surpasses that of female infertility in many places. Not everyone have access to the high-tech assisted reproduction techniques which compensate for any spermatogenesis. Many studies have been carried out in the hope of improving the sperm quality in men. Antioxidants play an important role in the spermiogenesis, but so far no product has been found that really meets the expectations of improving the spermatogenesis in the short term. A product that naturally or through low- tech assisted reproduction techniques improves the pregnancy rates among couples that suffer from this type of disorder.

Catalysis Laboratories is specialized in natural antioxidant products as adjuvants and alternative treatments for prevention, management and recovery from different diseases.

The aim of this clinical trial is to study the efficacy and safety of Spermotrnend, a natural product manufactured by Catalysis Laboratories, in the improvement of sperm's quality and quantity in male infertility as well as in urinary symptoms and varicocele in those patients who suffer it in association or not with infertility.

Details
Condition Male Infertility, Benign Prostatic Hyperplasia, Spermatogenesis and Semen Disorders
Treatment Spermotrend
Clinical Study IdentifierNCT05222841
SponsorCatalysis SL
Last Modified on22 March 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Males over 18
Patient who shows alterations of the spermatogenesis and/or benign prostatic hyperplasia
Patients without testicular pathology
Serology and HIV negative
Signed informed consent

Exclusion Criteria

Patients with associated pathologies: epididymo-orchitis, radiation or chemotherapy
Patients with a testicular pathology that has been resolved
Patients with non-transmissible chronic pathologies
Patients who have not agreed to take part in the study
Patients that are undergoing antioxidant treatment or who have completed this treatment in the last six months
Patients who are being treated with vitamins or who have completed this treatment in the last six months
Patients that are being treated with anti-inflammatory medications or who have completed this treatment in the last six months
Patients who are undergoing hormone treatment prescribed for andrology or who have completed this treatment in the last six months
Patients with serology or who are HIV positive
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note